Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality-of-Life Results for Patients Too High Risk for Surgery

March 10, 2013 11:30 am | by PR Newswire | News | Comments

SAN FRANCISCO, March 10, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced data from the EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) High Surgical Risk cohort evaluating the company's first-in-class catheter-based MitraClip® System for the treatment of mitral...

TOPICS:

Mazor Robotics Receives First Renaissance System Order From Australian Distribution Partner LifeHealthcare

March 10, 2013 4:00 am | by The Associated Press | News | Comments

CAESAREA, Israel--(BUSINESS WIRE)--Mar 10, 2013--Mazor Robotics Ltd. (TASE:MZOR), the developer of Renaissance™, an innovative surgical guidance system and its complementary products, today announced that LifeHealthcare, the Company’s distribution and marketing partner in Australia, has ordered...

TOPICS:

Boston Scientific Apologizes for Embargo Breach that Got Its Watchman Trial Pulled from Conference

March 9, 2013 11:16 pm | by Mass Device | News | Comments

American College of Cardiology conference organizers cancel the highly anticipated presentation of preliminary results from Boston Scientific's PREVAIL study after the company leaks the data ahead of time. Boston Scientific publishes the slides that would have been presented.

TOPICS:
Advertisement

Do Hybrid Cars Interfere With Cardiac Implants? Apparently Not, Study Finds

March 9, 2013 7:40 pm | by Mass Device | News | Comments

Mayo Clinic researchers examine the interaction between implantable cardiac devices and the electromagnetic interference generated by hybrid-electric vehicles, finding no reason for concern. In the 1st study of its kind to examine the interaction between hybrid cars and implantable cardiac devices, researchers found that the electromagnetic waves generated by the green vehicles don't pose a threat.

TOPICS:

The Boston Scientific Watchman@ Device Continues To Demonstrate Positive Clinical Outcomes For Patients With Atrial Fibrillation

March 9, 2013 2:24 pm | by The Associated Press | News | Comments

Boston Scientific Corporation (NYSE: BSX) reports preliminary data in the PREVAIL clinical trial met two out of three co-primary endpoints. The PREVAIL trial evaluates safety and efficacy of the WATCHMAN@ Left Atrial Appendage (LAA) Closure device in patients with nonvalvular atrial...

TOPICS:

Boston Scientific's Watchman Heart Implant Shows Improved Safety Profile in Preliminary Results

March 9, 2013 12:12 pm | by Mass Device | News | Comments

Boston Scientific hopes to reassure FDA regulators about the safety and efficacy of its Watchman stroke prevention implant with results from its PREVAIL study, the presentation for which was pulled from the lineup at the American College of Cardiology conference in San Francisco today.

TOPICS:

ACC13: Boston Scientific's PREVAIL clinical trial presentation canceled

March 9, 2013 11:54 am | by Mass Device | News | Comments

Medical device giant Boston Scientific (NYSE:BSX) will not present its highly anticipated PREVAIL clinical trial results at the American College of Cardiology conference as planned this morning after the presentation was canceled when the company leaked the data ahead of time.

TOPICS:

Presentation of Preliminary Results From Boston Scientific PREVAIL Clinical Trial Now Available

March 9, 2013 9:29 am | by Bio-Medicine.Org | News | Comments

Boston Scientific Corporation (NYSE: BSX ) announces the preliminary analysis of the PREVAIL clinical trial data is now available on TCTMD.  PREVAIL evaluates the safety and efficacy of the WATCHMAN® Left Atrial Appendage (LAA) Closure device in patients with nonvalvular atrial...

TOPICS:
Advertisement

STENTYS Self-Apposing® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack Trials

March 9, 2013 9:00 am | by The Associated Press | News | Comments

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Mar 9, 2013--STENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing ® Stent to treat acute myocardial infarction (AMI), announced today one-year results of the APPOSITION III...

TOPICS:

DNA Sequencing Giant Illumina Joins Hunt for Autism Blood Test

March 8, 2013 4:37 pm | by Massachusetts Institute of Technology | News | Comments

Illumina will work with SynapDx’s to find a blood-test that could allow treatment to start earlier. Massachusetts startup SynapDx announced on Wednesday that it will work with DNA sequencer manufacturer Illumina  to develop early detection tools for autism spectrum disorders, according to a release.

TOPICS:

Medical Device Tax and the iPhone: Grover Norquist's Anti-Tax Group Jumps on New Argument for Repeal

March 8, 2013 3:05 pm | by Mass Device | News | Comments

Conservative tax-reform activist Grover Norquist is putting some of his organization's muscle behind a mostly GOP-fueled effort to paint the medical device excise tax as a danger to smartphones and tablets. In an op-ed for The Hill, Katie McAuliffe wrote that there is legitimate concern that smartphones, tablets, and other hand-held devices could be unnecessarily taxed.

Jury Deems J&J's Depuy ASR XL Hip Implant Defective in Design, Orders $8.3M in Damages

March 8, 2013 2:20 pm | by Mass Device | News | Comments

A California jury ruled against Johnson & Johnson and its DePuy subsidiary in finding that the company's ASR XL metal-on-metal hip implant was defectively designed. The decision marks the highly anticipated close of the 1st of more than 10,750 such lawsuits against J&J.

TOPICS:

Report: Boston Scientific Issues Alert on Its Lead-Free S-ICD Defibrillator

March 8, 2013 1:43 pm | by Mass Device | News | Comments

Boston Scientific recently issued a warning on its lead-free implantable defibrillators over concerns that a fuse malfunction could prevent the devices from delivering life-savings shocks. The company has received reports of four instances in which a fuse inside the subcutaneous ICD was activated inappropriately.

TOPICS:

Women and Girls HIV/AIDS Awareness Day Sunday March 10th

March 8, 2013 1:18 pm | by PR Newswire | News | Comments

HOFFMAN ESTATES, Ill., March 8, 2013 /PRNewswire/ -- American women and girls will make up nearly a quarter of all new HIV infections in the United States this year, providing a stark reminder that increased HIV testing can save lives, Home Access Health Corporation, the leading...

Tucson Symposium Attracts Over 450 Global Scientists Focused on Personalized Healthcare

March 8, 2013 1:00 pm | by PR Newswire | News | Comments

TUCSON, Ariz., March 8, 2013 /PRNewswire/ -- For millions of patients, personalized healthcare, or fitting the right treatments to patients based on an individual's particular genetic make-up, means the difference between life and death. Our expanding knowledge of disease...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading